[Durgical](https://durgical.com/en/) › [DurgiPedia](https://durgical.com/en/durgipedia/) › [Histology](https://durgical.com/en/histology/) › [Methods and stains](https://durgical.com/en/histology/areas/methods/) › Immunohistochemistry and in situ hybridization (FISH)

# Immunohistochemistry and in situ hybridization (FISH)

- Technique

Many tumours look alike under the microscope; tagging one protein or gene inside the cells tells the pathologist what the tumour really is.

Updated Nov 15, 2026

## Key points

- IHC = antibody against a protein; ISH = nucleic acid probe against DNA or RNA; FISH = fluorescent ISH.
- Indirect IHC (secondary antibody) amplifies the signal and is the usual method.
- HER2: IHC measures protein, FISH counts gene copies; FISH resolves equivocal IHC.
- Cytokeratin = carcinoma; CD45 = lymphoma; S-100/SOX10 = [melanoma](https://durgical.com/en/conditions/melanoma/).

## What it is

Immunohistochemistry (IHC) uses [antibodies](https://durgical.com/en/biochemistry/enzymes/immunoglobulins/) against a specific protein to locate it in a tissue section; the bound antibody is made visible with an enzyme that leaves a coloured deposit (often brown) or with a fluorescent dye. In situ hybridization (ISH) uses labelled nucleic acid probes that bind complementary DNA or RNA sequences; with fluorescent probes (FISH) it shows gene amplifications, deletions and translocations in individual nuclei. Both keep the tissue architecture, so the result is tied to the cells that carry it.

## How to think about it

Both are a lock-and-key search done on the slide itself: the key (an antibody for a protein, a probe for a DNA or RNA sequence) sticks only to its target, and a label marks where it stuck. Because the tissue stays intact, you learn not only whether the target is there but which cells carry it and where in the cell.

## Key facts

- Cytokeratins mark epithelial cells: carcinoma versus lymphoma or melanoma.
- CD45 marks [leukocytes](https://durgical.com/en/physiology/white-blood-cells-types-and-functions/); CD20 B cells and CD3 T cells classify lymphomas.
- S-100, SOX10 and melan-A mark melanocytic and neural crest cells (melanoma).
- Oestrogen receptor and HER2 in [breast cancer](https://durgical.com/en/conditions/breast-cancer/) guide targeted therapy; HER2 FISH settles an equivocal IHC.
- EBER ISH shows [Epstein–Barr virus](https://durgical.com/en/microbiology/epstein-barr-virus/) RNA in EBV-related lymphomas and [nasopharyngeal carcinoma](https://durgical.com/en/conditions/nasopharyngeal-carcinoma/).

## Step by step

- The section is deparaffinized and its antigens are unmasked, usually by heating.
- A primary antibody against the target protein is applied and binds it.
- Indirect method (the usual one): labelled secondary antibodies bind the primary, several per primary, amplifying the signal.
- An enzyme such as peroxidase turns a chromogen into a brown deposit where the antigen sits.
- Haematoxylin counterstain; the reader notes which cells stain and where (membrane, cytoplasm or nucleus).
- For FISH, DNA in the nuclei is denatured, a fluorescent probe binds its [matching](https://durgical.com/en/epidemiology/matching/) sequence and signals are counted per nucleus.

## IHC versus in situ hybridization

| Feature | Immunohistochemistry (IHC) | In situ hybridization (ISH, FISH) |
| --- | --- | --- |
| Target | A protein (antigen) | A DNA or RNA sequence |
| Probe | Antibody | Labelled complementary nucleic acid |
| Read-out | Coloured deposit (brown) or fluorescence | Fluorescent dots (FISH) or a coloured deposit (chromogenic ISH) |
| Question answered | Is the protein present, in which cells and where? | How many gene copies, is the gene broken or moved, is viral RNA present? |
| [Classic use](https://durgical.com/en/conditions/breast-cancer/) | HER2 protein, oestrogen receptor, lineage markers | HER2 amplification, BCR-ABL1 fusion, EBER (Epstein–Barr virus RNA) |

## Clinical notes

- For a metastasis of unknown primary, a panel of IHC markers (for example CK7, CK20, TTF-1, CDX2) points to the likely site of origin.
- Ki-67 IHC estimates the fraction of dividing cells and helps grade tumours.
- FISH also detects translocations such as BCR::ABL1 in leukaemia and gene rearrangements in some sarcomas and lymphomas.
- Mismatch-repair protein IHC screens colorectal and endometrial cancers for [Lynch syndrome](https://durgical.com/en/conditions/lynch-syndrome/).

## Common traps

- **A brown IHC stain means the cell is malignant**: it only shows the protein is present; benign cells express most markers, so the pattern decides, not the colour.
- **A positive cytokeratin tells you which organ the tumour came from**: it shows epithelial origin only; the site comes from a panel such as CK7, CK20, TTF-1 and CDX2.
- **HER2 IHC and HER2 FISH measure the same thing**: IHC sees the protein on the membrane and FISH counts gene copies, which is why FISH resolves an equivocal IHC.
- **Where the stain sits in the cell does not matter**: a nuclear marker such as oestrogen receptor or Ki-67 must stain the nucleus, so location is part of the result.

## Test yourself

Think of the answer, then tap the question to see it.

## A poorly differentiated tumour in a lymph node is cytokeratin-negative and CD45-positive. What is it most likely, and why?

A lymphoma: CD45 marks leukocytes, and the absence of cytokeratin argues against carcinoma.

## Why is the indirect IHC method more sensitive than the direct method?

Several labelled secondary antibodies bind each primary antibody, so each antigen collects more label.

## HER2 IHC on a breast cancer is equivocal. What test comes next, and what does it measure?

HER2 FISH, which counts HER2 gene copies per nucleus to decide whether the gene is amplified.

## Why does IHC show which cells express a protein when a test on ground-up tissue cannot?

The section keeps the architecture, so the stain lands on particular cells and compartments; an extract mixes all cells together.

[Add to my cards (4)](https://durgical.app/estudiar/?add=/en/histology/immunohistochemistry-and-in-situ-hybridization/)

## Connections

## Related 3

- [Microscopy and stains: H&E, PAS, trichrome, silver, immunohistochemistry](https://durgical.com/en/histology/microscopy-and-stains-h-y-e-pas-trichrome-silver-immunohistochemistry/)
- [Light microscopes: fluorescence, phase-contrast, confocal, polarized](https://durgical.com/en/histology/light-microscopes-fluorescence-phase-contrast-confocal-polarized/)
- [From biopsy to slide: fixation, sectioning, frozen section](https://durgical.com/en/histology/from-biopsy-to-slide-fixation-sectioning-frozen-section/)

## Related conditions 2

- [Breast cancer](https://durgical.com/en/conditions/breast-cancer/)
- [Carcinoma of unknown primary](https://durgical.com/en/conditions/carcinoma-of-unknown-primary/)

[← All of histology](https://durgical.com/en/histology/)

Educational content on normal microscopic structure and its clinical relevance; no substitute for studying slides or for a health professional's advice.

Sources: [HER2 Tumor Marker Test: MedlinePlus Medical Test](https://medlineplus.gov/lab-tests/her2-tumor-marker-test/) (MedlinePlus, US National Library of Medicine, 2025); [Pathology Reports](https://www.cancer.gov/about-cancer/diagnosis-staging/diagnosis/pathology-reports-fact-sheet) (National Cancer Institute, 2024).

## **Spotted a mistake?** We are always improving for the community. Tell us what is wrong and our team will review it. Report a mistake

Representative model, for educational purposes only.

---
Source: https://durgical.com/en/histology/immunohistochemistry-and-in-situ-hybridization/
License: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Cite as: DurgiPedia (durgical.com), https://durgical.com/en/histology/immunohistochemistry-and-in-situ-hybridization/
